Name: New Drug Session: What Compounds Are Up Next?
Uploaded: 2019-03-21T16:45:00-04:00
Duration: T7M20S
Description: This video discusses a combination of 2 approved drugs, netarsudil and latanoprost, the addition of nitric oxide to other prostaglandins, trabecular protection, neuroprotection, gene therapy, and cell-based therapies.

Shop

Clinical Education /

Multimedia /

Video /

Presentations and Lectures

MAR 21, 2019

New Drug Session: What Compounds Are Up Next?

By John R Samples, MD

Glaucoma Subspecialty Day 2018

07:20

Glaucoma

Add to My Bookmarks

View

Mark Complete

Remove

Comments

This video discusses a combination of 2 approved drugs, netarsudil and latanoprost, the addition of nitric oxide to other prostaglandins, trabecular protection, neuroprotection, gene therapy, and cell-based therapies.

Related

Early Tube Complications

Apr 19, 2024

Trabeculectomy Complications

Apr 19, 2024

Uveitic Childhood Glaucoma: Goniotomy’s Role, Steroid Response

Apr 19, 2024

How to Not Let Those Flat Chambers Get You Down

Apr 17, 2024

Angle Surgery Complications: Hyphema and Hypotony

Apr 17, 2024
Most Commented

Loading, please wait...

There are no comments available.

Most Viewed

Loading, please wait...

Most Viewed content is not available.

All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.

New Drug Session: What Compounds Are Up Next?

OUR SITES

FOLLOW THE ACADEMY

New Drug Session: What Compounds Are Up Next?

Related

OUR SITES

FOLLOW THE ACADEMY